Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models
| Autor: | Pierre Mahy, Vincent Grégoire, Daniel Labar, Marc De Bast, J. Gillart, Karin Haustermans, Arnaud Cheguillaume, Tjibbe de Groot |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Male
Fluorine Radioisotopes Biodistribution Pathology medicine.medical_specialty Pharmacology Excretion Mice Pharmacokinetics Carbogen medicine Animals Tissue Distribution Radiology Nuclear Medicine and imaging Misonidazole Hypoxia Gamma counter Mice Inbred C3H Kidney Tumor hypoxia Chemistry Neoplasms Experimental Hematology medicine.anatomical_structure Oncology Nitroimidazoles Radiopharmaceuticals FMISO |
| Zdroj: | Radiotherapy and Oncology. 89:353-360 |
| ISSN: | 0167-8140 |
| Popis: | BACKGROUND AND PURPOSE: [(18)F]-EF3 allows non-invasive detection of hypoxia. In the framework of its validation, we aimed at comparing its pharmacokinetics, biodistribution, metabolism and specificity for hypoxia with the hypoxia tracer [(18)F]-FMISO. MATERIALS AND METHODS: C3H mice were injected IV with 3.7-18.5MBq of one of the two tracers. For pharmacokinetics experiments, blood, urines and feces were collected. For biodistribution experiments, 13 different organs were harvested. To assess the hypoxia-specificity of the tracers, intramuscular syngeneic FSA II tumor bearing mice breathing air or carbogen were used. Animals were sacrificed from 5 to 440min after injection. Radioactivity was assessed ex-vivo in a gamma counter. Tracer metabolites were assessed with radio-HPLC of acetonitrile soluble fractions of tissues. RESULTS: Elimination half-life in blood (mono-exponential fit) reached 81.8 and 99.7min for [(18)F]-EF3 and [(18)F]-MISO, respectively (NS). After 440min, 71+/-7% (mean+/-SD) of injected activity of [(18)F]-EF3 was collected in the urine while 9+/-2% was collected in the feces, compared to 71+/-15% and 23+/-15% for [(18)F]-MISO (NS). Biodistribution was similar with a homogeneous distribution in most organs as early as 5min after injection. With time, an increased activity in organs involved in excretion (kidney, bladder, liver and GI tract) was measured for both tracers; however, an increased background activity in "oxic" normal tissues (brain, lung, and esophagus) was also observed for [(18)F]-MISO. The percentage of metabolites was higher for [(18)F]-MISO compared to [(18)F]-EF3 in nearly all samples. Tumor-to-muscle ratios (TMRs) ranging from 2 to 4 were obtained under air-breathing condition for both tracers. CONCLUSION: Both tracers exhibited a similar pharmacokinetics and biodistribution in mice and accumulated in an hypoxia-dependent manner in tumors. However, more aspecific activity was observed with [(18)F]-MISO at late time points after tracer injection in normal tissues. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect